Subsequent investigation revealed that HDAC6 was markedly increased in the model group, and down-regulated after SPRC treatment (Figure 4A), indicating that HDAC6 is a pro-RA factor and can be depressed by CSE. This evidence concerns the gene CTH and rheumatoid arthritis.